Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammation and insulin resistance.

Steven E Shoelson1, Jongsoon Lee, Allison B Goldfine

  • 1Joslin Diabetes Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215, USA. steven.shoelson@joslin.harvard.edu

The Journal of Clinical Investigation
|July 11, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ginsenoside Rd attenuates renal aging and fibrosis through inhibition of angiotensin II type 1 receptor signaling.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Using human genetic variation to estimate the effect of lipoprotein(a) lowering on pregnancy outcomes.

medRxiv : the preprint server for health sciences·2026
Same author

A Phase 2 (2a) Randomized Trial of Iscalimab in Adolescents and Young Adults with New-Onset Type 1 Diabetes.

Diabetes technology & therapeutics·2025
Same author

Complete loss of SLC30A8 in humans improves glucose metabolism and beta cell function.

Diabetologia·2025
Same author

Inducible skeletal muscle-specific p53 deletion alleviates high-fat diet-induced insulin resistance by modulating mitochondria-associated membrane in obese mice.

Redox biology·2025
Same author

Immunogenicity assessment strategy for a chemically modified therapeutic protein in clinical development.

Frontiers in immunology·2024

Salicylates can lower glucose levels, suggesting a link between inflammation and type 2 diabetes (T2D). New research connects inflammation, macrophages, and obesity to T2D, offering anti-inflammatory treatment strategies.

Area of Science:

  • Immunology
  • Metabolic Diseases
  • Endocrinology

Background:

  • High-dose salicylates historically lowered glucose in diabetic patients, hinting at an inflammation-diabetes link.
  • The connection between salicylate's anti-inflammatory and antihyperglycemic effects and insulin resistance pathogenesis was recently established.
  • Tissue macrophages play a crucial role in the development of type 2 diabetes (T2D) and metabolic syndrome.

Purpose of the Study:

  • To explore the link between inflammation and insulin resistance in type 2 diabetes (T2D).
  • To understand how obesity contributes to T2D risk through inflammatory pathways.
  • To identify new therapeutic opportunities using anti-inflammatory strategies for metabolic disorders.

Main Methods:

  • Review of historical salicylate studies.

Related Experiment Videos

  • Analysis of recent findings on tissue macrophages and inflammation.
  • Exploration of the immunological basis of insulin resistance.

    • Main Results:

    • Salicylates possess both antihyperglycemic and anti-inflammatory properties.
    • Obesity's risk for T2D is increasingly understood through inflammatory mechanisms involving macrophages.
    • Insulin resistance and T2D are recognized as having significant immunological components.

    Conclusions:

    • Inflammation critically modulates metabolism, impacting T2D development.
    • Anti-inflammatory strategies show promise for treating metabolic consequences of obesity.
    • A paradigm shift is occurring, viewing T2D and insulin resistance through an immunological lens.